Latest Amgen Stories
Data From Pivotal Trial Published in the New England Journal of Medicine and Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition THOUSAND OAKS, Calif.
THOUSAND OAKS, Calif., Dec.
Quimioterapia: Mitos y Realidades Aimed at Helping Spanish-Speaking Patients and Caregivers Take Control of Their Chemotherapy Journey THOUSAND OAKS, Calif., Dec.
Study Met All Primary Endpoints Against Stelara® (ustekinumab) and Placebo THOUSAND OAKS, Calif. and LONDON, Nov.
THOUSAND OAKS, Calif., Nov.
ResearchMoz.us include new market research report " China Recombinant Protein Drug Industry, 2014-2017: Market Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection
Surveyed European Oncologists Expect to Use Future Biosimilar G-CSFs in a Greater Proportion of Eligible Patients than Biosimilar MAbs, According to Findings from Decision Resources Group BURLINGTON,
Additional Data Analysis Showed Every Two Week and Monthly Dosing Regimens of Evolocumab Were Clinically Equivalent THOUSAND OAKS, Calif., Nov.
THOUSAND OAKS, Calif., Nov. 14, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will participate at the Jefferies Global Healthcare Conference on Wednesday, Nov.
RnRMarketResearch.com adds "Hematopoietic Stem Cell Transplantation – Pipeline Review, H2 2014" to its store.
- A serpent whose bite was fabled to produce intense thirst.